In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in the IVD Test Procedure Volumes, 2019-2024 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.
The range of IVD procedures includes point-of-care and laboratory tests that are categorized according to the testing technology employed. Approximately 20 different technologies have been adapted to IVD applications. The pursuit of needed improvements in healthcare resources and capabilities will boost growth opportunities for IVD procedures and products in the majority of developing countries.
Point-of-care (POC) testing encompasses diagnostic procedures performed in physicians’ offices, hospital rooms and departments (ICU, emergency, etc.), clinics, ambulances, nursing homes, pharmacies, private residences, and other venues where patients interact directly with medical professionals. This activity also includes the self-monitoring and self-detection of diseases, disorders, and other health conditions by individuals. Growth in the global volume of POC procedures will build upward momentum from several trends and factors.
Clinical chemistry enables the measurement of naturally produced and externally consumed compounds in the body. Increasing applications in basic physical examinations, routine patient check-ups, and the pre-admission and pre-discharge testing of hospital patients are predicted to boost the total global volume of laboratory clinical chemistry procedures.
The science of molecular diagnostics compares DNA, RNA, genes, or proteins found in extracted human specimens to reference probes containing genetic matter linked to specific diseases, disorders or other medical conditions. Molecular assays continue to penetrate new and existing applications based on selectivity, sensitivity, speed, and accuracy advantages over alternative diagnostics. Molecular technologies will assume an increasingly important role in patient testing as breakthroughs in human genomic and proteomic fields are leading to the discovery of new genetic disease markers.
Hematology testing is widely implemented as part of basic patient examinations, pre-hospital admission screens, and initial emergency room evaluations.
Coagulation tests diagnose and monitor various bleeding disorders and evaluate the effectiveness of blood-related therapies, notably anticoagulant agents such as heparin and warfarin, with increasing applications in surgical, inpatient, and emergency care underlying gains.
Conventional microbiology testing is implemented globally to detect and analyze infectious diseases and related conditions. Spurred by upward trends in the incidence of infectious diseases, the global volume of conventional microbiology procedures is forecast to increase.
The blood banking segment applies IVD products to three major applications: the screening of donated blood for viral antigens, the matching of blood types between organ donors and recipients, and the identification of blood grouping and platelet antibodies.
Histology and cytology are branches of clinical pathology that provide for the in vitro detection and analysis of various diseases and disorders. Histology procedures involve the examination of tissues, while cytology testing is performed on cells. Gains in these two disciplines reflect expanding use in cancer screening and diagnosis and, to a lesser extent, in the detection of infectious diseases and genetic disorders.
Immunoassays tests can be used to identify any medical condition that triggers an in vivo immune response, including cancer, cardiovascular damage, drug abuse, infectious and viral diseases, infertility, pregnancy, and thyroid disorders. They are also employed widely in therapeutic drug monitoring to evaluate the effectiveness of medicines against various tumors and pathogenic microorganisms.
IVD Test Procedure Volumes estimates IVD test procedure volume and IVD pricing for the following segments:
- Worldwide IVD Market and Test Volume
- Point-of-Care Market and Test Volume
- Clinical Chemistry Market and Test Volume
- Molecular Market and Test Volume
- Hematology Market and Test Volume
- Coagulation Market and Test Volume
- Microbiology Market and Test Volume
- Blood Screening Market and Test Volume
- Histology/Cytology Market and Test Volume
- Immunoassay Market and Test Volume
IVD Testing Segments and Global IVD Markets
The range of IVD procedures includes point-of-care and laboratory tests that are categorized according to the testing technology employed. Approximately 20 different technologies have been adapted to IVD applications. The pursuit of needed improvements in healthcare resources and capabilities will boost growth opportunities for IVD procedures and products in the majority of developing countries.
The report provides the following IVD testing data points:
- Global IVD Procedure Volumes, 2019 and 2024
- Global IVD Procedural Volume & Product Sales (excludes glucose tests), 2019-2024 (IVD Procedures [million], $ products/procedures, IVD Product Sales [$ millions])
- IVD Procedural Volume including blood glucose tests (millions), 2019-2024 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
- IVD Procedural Volume excluding blood glucose tests (millions), 2019-2024 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
- IVD Product Sales including blood glucose tests ($ millions), 2019-2024 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
- IVD Product Sales excluding blood glucose tests ($ millions), 2019-2024 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
- IVD Procedural Volume excluding blood glucose tests by Region (millions), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
- IVD Product Sales excluding blood glucose tests by Region ($ millions), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
Point-of-Care (POC) Procedures
Point-of-care (POC) testing encompasses diagnostic procedures performed in physicians’ offices, hospital rooms and departments (ICU, emergency, etc.), clinics, ambulances, nursing homes, pharmacies, private residences, and other venues where patients interact directly with medical professionals. This activity also includes the self-monitoring and self-detection of diseases, disorders, and other health conditions by individuals. Growth in the global volume of POC procedures will build upward momentum from several trends and factors.
The report provides the following POC data points:
- Total POC Procedural Volume & Product Sales including blood glucose tests, 2019-2024 (Self-Tests, Professional Tests)
- Total POC Procedural Volume & Product Sales excluding blood glucose tests, 2019-2024 (Self-Tests, Professional Tests)
- POC Self-Test Procedural Volume by Type (millions), 2019-2024 (Conventional Glucose, Continuous Glucose, Pregnancy/Ovulation, Fecal Occult Blood, Coagulation, Drugs of Abuse, Urinalysis, Cholesterol/Lipids, H. pylori, HIV, Other, Total, Total w/o glucose)
- POC Self-Test Product Sales by Type ($ millions), 2019-2024 (Conventional Glucose, Continuous Glucose, Pregnancy/Ovulation, Fecal Occult Blood, Coagulation, Drugs of Abuse, Urinalysis, Cholesterol/Lipids, H. pylori, HIV, Other, Total, Total w/o glucose)
- POC Self-Test $ IVD Product Sales Per Procedure, 2019-2024 (Conventional Glucose, Continuous Glucose, Pregnancy/Ovulation, Fecal Occult Blood, Coagulation, Drugs of Abuse, Urinalysis, Cholesterol/Lipids, H. pylori, HIV, Other, Average, Average w/o glucose)
- POC Professional Procedural Volume by Type (millions), 2019-2024 (Glucose, Infectious Diseases, Critical Care, Coagulation, Fecal Occult Blood, Cardiac Markers, Hematology, Drugs of Abuse, Cholesterol/Lipids, HbA1c, Fertility, Other, Total, Total w/o glucose)
- POC Professional IVD Product Sales by Type ($ millions), 2019-2024 (Glucose, Infectious Diseases, Critical Care, Coagulation, Fecal Occult Blood, Cardiac Markers, Hematology, Drugs of Abuse, Cholesterol/Lipids, HbA1c, Fertility, Other, Total, Total w/o glucose)
- POC Professional $ IVD Products Per Procedure by Type (millions), 2019-2024 (Glucose, Infectious Diseases, Critical Care, Coagulation, Fecal Occult Blood, Cardiac Markers, Hematology, Drugs of Abuse, Cholesterol/Lipids, HbA1c, Fertility, Other, Total, Total w/o glucose)
Clinical Chemistry Procedures
Clinical chemistry enables the measurement of naturally produced and externally consumed compounds in the body. Increasing applications in basic physical examinations, routine patient check-ups, and the pre-admission and pre-discharge testing of hospital patients are predicted to boost the total global volume of laboratory clinical chemistry procedures.
IVD Test Procedure Volumes provides the following data points with respect to clinical chemistry procedures:
- Clinical Chemistry Procedural Volume by Type (millions), 2019-2024 (General Chemistry, Blood Gas Analysis, Urinalysis)
- Clinical Chemistry Product Sales by Type ($ millions), 2019-2024 (General Chemistry, Blood Gas Analysis, Urinalysis)
- Clinical Chemistry $ IVD Product Sales Per Procedure ($), 2019-2024 (General Chemistry, Blood Gas Analysis, Urinalysis)
Molecular Testing Procedures
The science of molecular diagnostics compares DNA, RNA, genes, or proteins found in extracted human specimens to reference probes containing genetic matter linked to specific diseases, disorders or other medical conditions. Molecular assays continue to penetrate new and existing applications based on selectivity, sensitivity, speed, and accuracy advantages over alternative diagnostics. Molecular technologies will assume an increasingly important role in patient testing as breakthroughs in human genomic and proteomic fields are leading to the discovery of new genetic disease markers.
The report provides the following molecular assay data points:
- Molecular Assay Procedural Volume by Type (millions), 2019-2024 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
- Molecular Assay Infectious Disease Procedural Volume by Type (millions), 2019-2024 (HAIs, Hepatitis, HIV, HPV, GC/Chlamydia, Respiratory, Mycobacteria/TB, Organism ID, Other)
- Molecular Assay Product Sales by Type ($ millions), 2019-2024 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
- Molecular Assay Infectious Disease Product Sales by Type ($ millions), 2019-2024 (HAIs, Hepatitis, HIV, HPV, GC/Chlamydia, Respiratory, Mycobacteria/TB, Organism ID, Other)
- Molecular Assays $ Products per Procedure by Type, 2019-2024 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
Hematology Procedures
Hematology testing is widely implemented as part of basic patient examinations, pre-hospital admission screens, and initial emergency room evaluations.
The report provides the following data points with respect to hematology procedures:
- Hematology Procedural Volume by Type (millions), 2019-2024 (Complete Blood Count, Other Hematology Tests)
- Hematology Product Sales by Type ($ millions), 2019-2024 (Complete Blood Count, Other Hematology Tests)
- Hematology $ Product Sales Per Procedure by Type, 2019-2024 (Complete Blood Count, Other Hematology Tests)
Coagulation Testing Procedures
Coagulation tests diagnose and monitor various bleeding disorders and evaluate the effectiveness of blood-related therapies, notably anticoagulant agents such as heparin and warfarin, with increasing applications in surgical, inpatient, and emergency care underlying gains.
The report provides the following coagulation testing data points:
- Coagulation Procedural Volume (millions), 2019-2024
- Coagulation Product Sales ($ millions), 2019-2024
- Coagulation $ Products per Procedure, 2019-2024
Microbiology Procedures
Conventional microbiology testing is implemented globally to detect and analyze infectious diseases and related conditions. Spurred by upward trends in the incidence of infectious diseases, the global volume of conventional microbiology procedures is forecast to increase.
IVD Test Procedure Volumes provides the following data points with respect to microbiology procedures:
- Conventional Microbiology Procedural Volume by Type (millions), 2019-2024 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
- Conventional Microbiology Product Sales by Type ($ millions), 2019-2024 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
- Conventional Microbiology $ Product Sales Per Procedures by Type, 2019-2024 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
Blood Grouping/Typing Procedures
The blood banking segment applies IVD products to three major applications: the screening of donated blood for viral antigens, the matching of blood types between organ donors and recipients, and the identification of blood grouping and platelet antibodies.
The report provides estimates of procedures, product sales, and prices appearing applying to blood grouping and typing functions only:
- Blood Grouping/Matching Procedural Volume (millions), 2019-2024
- Blood Grouping/Matching Product Sales ($ millions), 2019-2024
- Blood Grouping/Matching $ Product Sales/Procedure, 2019-2024
Histology/Cytology Procedures
Histology and cytology are branches of clinical pathology that provide for the in vitro detection and analysis of various diseases and disorders. Histology procedures involve the examination of tissues, while cytology testing is performed on cells. Gains in these two disciplines reflect expanding use in cancer screening and diagnosis and, to a lesser extent, in the detection of infectious diseases and genetic disorders.
The report provides the following histology/cytology data points:
- Histology/Cytology Procedural Volume by Type (millions), 2019-2024 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
- Histology/Cytology Product Sales by Type ($ millions), 2019-2024 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
- Histology/Cytology $ Product Sales Per Procedure by Type, 2019-2024 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
Immunoassay Procedures
Immunoassays tests can be used to identify any medical condition that triggers an in vivo immune response, including cancer, cardiovascular damage, drug abuse, infectious and viral diseases, infertility, pregnancy, and thyroid disorders. They are also employed widely in therapeutic drug monitoring to evaluate the effectiveness of medicines against various tumors and pathogenic microorganisms.
IVD Test Procedure Volumes provides the following data points with respect to immunoassay procedures:
- Immunoassay Procedural Volume by Type (millions), 2019-2024 (Cardiac Markers, Tumor Markers, Autoimmune Markers, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Other Analytes; Total Lab-Based Immunoassays, Infectious Diseases, Blood Screening)
- Immunoassay Product Sales by Type ($ millions), 2019-2024 (Cardiac Markers, Tumor Markers, Autoimmune Markers, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Other Analytes; Total Lab-Based Immunoassays, Infectious Diseases, Blood Screening)
- Immunoassay $ Product Sales Per Procedure by Type, 2019-2024 (Cardiac Markers, Tumor Markers, Autoimmune Markers, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Other Analytes; Total Lab-Based Immunoassays, Infectious Diseases, Blood Screening)
Table of Contents
One: Executive Summary- Figure 1-1 Global IVD Procedure Volumes, 2019 and 2024
- IVD Procedure Volume Estimate and Forecast
- Scope & Methodology
- About the Author
Two: Introduction
Industry Trends
- Table 2-1 Global IVD Procedural Volume & Product Sales (excludes glucose tests), 2019-2024 (IVD Procedures [million], $ products/procedures, IVD Product Sales [$ millions])
Three: Healthcare Trends
- Overview
- Global Macroeconomic Environment
Global Economic Outlook
- Table 3-1 Gross Domestic Product by Region ($ trillion), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
- Per Capita Gross Domestic Product
- Table 3-2 Per Capita GDP ($), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
Demographic Trends
- Total Population
- Table 3-3 Population by Region (million persons), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
- Age Distribution
- Table 3-4 Population 50 Years & Older by Region (million persons), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
- Table 3-5 Population 65 Years & Older by Region (million persons), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
Global Healthcare Trends
- Health Expenditures
- Table 3-6 Health Expenditures by Region ($ billion), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
- Hospitals
- Table 3-7 Number of Acute Care Hospitals by Region (thousand), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
- Physicians
- Table 3-8 Number of Practicing Physicians by Region (thousands), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
Clinical Laboratories
- Patient Activity
- Table 3-9 Number of Hospital Admissions by Region (millions), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
- Table 3-10 Number of Surgical Procedures by Region (millions), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
- Table 3-11 Number of Outpatient Consultations by Region (millions), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
Four: IVD Testing Segments
- IVD Testing Trends
- Table 4-1 IVD Procedural Volume including blood glucose tests (millions), 2019-2024 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
- Table 4-2 IVD Procedural Volume excluding blood glucose tests (millions), 2019-2024 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
Segment Growth Projections
- POC Testing
- Clinical Chemistry
- Immunoassays
- Molecular Assays
- Hematology
- Conventional Microbiology
- Coagulation
- Blood Grouping/Matching
- Histology/Cytology
- Table 4-3 IVD Product Sales including blood glucose tests ($ millions), 2019-2024 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
- Table 4-4 IVD Product Sales excluding blood glucose tests ($ millions), 2019-2024 (POC Self Testing, POC Professional Tests, Clinical Chemistry, Immunoassays, Molecular, Hematology, Coagulation, Conventional Microbiology, Blood Grouping/Typing, Histology/Cytology)
Five: Global IVD Markets
- General
- Table 5-1 IVD Procedural Volume excluding blood glucose tests by Region (millions), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
- Table 5-2 IVD Product Sales excluding blood glucose tests by Region ($ millions), 2019-2024 (North America: United States, Canada & Mexico; Central & South America; Western Europe; Eastern Europe; Asia/Pacific: China, Japan, Other Countries & Territories; Middle East; Africa; World)
North America
- United States
- Canada
- Mexico
Central & South America
- Brazil
- Other Central & South America
Western Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Other Western Europe
Eastern Europe
- Russia
- Other Eastern Europe
Asia/Pacific
- China
- India
- Japan
- South Korea
- Australia
- Other Asia/Pacific
Middle East
- Turkey
- Other Middle East
Africa
Six: Point-of-Care (POC) Procedures
Global POC Procedure Volume by Test Type
Table 6-1 Total POC Procedural Volume & Product Sales including blood glucose tests, 2019-2024 (Self-Tests, Professional Tests)
Table 6-2 Total POC Procedural Volume & Product Sales excluding blood glucose tests, 2019-2024 (Self-Tests, Professional Tests)
POC Self Tests
- Table 6-3 POC Self-Test Procedural Volume by Type (millions), 2019-2024 (Conventional Glucose, Continuous Glucose, Pregnancy/Ovulation, Fecal Occult Blood, Coagulation, Drugs of Abuse, Urinalysis, Cholesterol/Lipids, H. pylori, HIV, Other, Total, Total w/o glucose)
- Traditional Blood Glucose Monitoring Activities
- Continuous Blood Glucose Monitoring
- Pregnancy/Ovulation Tests
- Fecal Occult Blood Tests
- Coagulation Testing
- Drugs of Abuse Tests
- Urinalysis Tests
- Cholesterol Testing
- HIV Tests
- H. Pylori Testing
- Other POC Self-Tests
POC Self-Testing Product Sales
- Table 6-4 POC Self-Test Product Sales by Type ($ millions), 2019-2024 (Conventional Glucose, Continuous Glucose, Pregnancy/Ovulation, Fecal Occult Blood, Coagulation, Drugs of Abuse, Urinalysis, Cholesterol/Lipids, H. pylori, HIV, Other, Total, Total w/o glucose)
Pricing Trends
- Table 6-5 POC Self-Test $ IVD Product Sales Per Procedure, 2019-2024 (Conventional Glucose, Continuous Glucose, Pregnancy/Ovulation, Fecal Occult Blood, Coagulation, Drugs of Abuse, Urinalysis, Cholesterol/Lipids, H. pylori, HIV, Other, Average, Average w/o glucose)
POC Professional Tests
- Table 6-6 POC Professional Procedural Volume by Type (millions), 2019-2024 (Glucose, Infectious Diseases, Critical Care, Coagulation, Fecal Occult Blood, Cardiac Markers, Hematology, Drugs of Abuse, Cholesterol/Lipids, HbA1c, Fertility, Other, Total, Total w/o glucose)
- POC Professional Blood Glucose Testing Procedures
- POC Professional Infectious Disease Testing
- POC Professional Critical Care Testing
- POC Professional Coagulation Testing
- POC Professional Fecal Occult Blood Screening
- POC Professional Cardiac Marker Testing
- POC Professional Drugs of Abuse Testing
- POC Professional Cholesterol/Lipid Testing
- POC Professional HbA1C Testing
- POC Pregnancy/Ovulation Testing
- Other POC Professional Testing
POC IVD Product Sales
- Table 6-7 POC Professional IVD Product Sales by Type ($ millions), 2019-2024 (Glucose, Infectious Diseases, Critical Care, Coagulation, Fecal Occult Blood, Cardiac Markers, Hematology, Drugs of Abuse, Cholesterol/Lipids, HbA1c, Fertility, Other, Total, Total w/o glucose)
Pricing Trends
- Table 6-8 POC Professional $ IVD Products Per Procedure by Type (millions), 2019-2024 (Glucose, Infectious Diseases, Critical Care, Coagulation, Fecal Occult Blood, Cardiac Markers, Hematology, Drugs of Abuse, Cholesterol/Lipids, HbA1c, Fertility, Other, Total, Total w/o glucose)
Seven: Clinical Chemistry Procedures
- Table 7-1 Clinical Chemistry Procedural Volume by Type (millions), 2019-2024 (General Chemistry, Blood Gas Analysis, Urinalysis)
Types of Tests
- General Chemistry
- Blood Gases & Electrolytes
- Urinalysis
Global Sales of Clinical Chemistry Products
- Table 7-2 Clinical Chemistry Product Sales by Type ($ millions), 2019-2024 (General Chemistry, Blood Gas Analysis, Urinalysis)
Pricing Trends
- Table 7-3 Clinical Chemistry $ IVD Product Sales Per Procedure ($), 2019-2024 (General Chemistry, Blood Gas Analysis, Urinalysis)
Eight: Immunoassay Procedures
- Technologies
- Labeling Techniques
Enzyme Immunoassays
- Fluorescence Polarization Immunoassays (FPIAs)
- Radioimmunoassays (RIAs)
Testing Procedures & Product Sales
- Table 8-1 Immunoassay Procedural Volume by Type (millions), 2019-2024 (Cardiac Markers, Tumor Markers, Autoimmune Markers, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Other Analytes; Total Lab-Based Immunoassays, Infectious Diseases, Blood Screening)
- Table 8-2 Immunoassay Product Sales by Type ($ millions), 2019-2024 (Cardiac Markers, Tumor Markers, Autoimmune Markers, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Other Analytes; Total Lab-Based Immunoassays, Infectious Diseases, Blood Screening)
- Cardiac Markers
- Allergy Conditions
- Tumor Markers
- Proteins
- Vitamin D
- Autoimmune Conditions
- Thyroid Conditions
- Anemia
- Diabetes/HbA1c
- Drugs of Abuse
- Therapeutic Drug Monitoring
- Fertility Testing
- Other Analytes
- Infectious Diseases
- Blood Screening
Instruments
- Pricing Trends
- Table 8-3 Immunoassay $ Product Sales Per Procedure by Type, 2019-2024 (Cardiac Markers, Tumor Markers, Autoimmune Markers, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Other Analytes; Total Lab-Based Immunoassays, Infectious Diseases, Blood Screening)
Nine: Molecular Testing Procedures
- Table 9-1 Molecular Assay Procedural Volume by Type (millions), 2019-2024 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
Types of Test
- Testing Technologies
- Infectious Diseases
- Table 9-2 Molecular Assay Infectious Disease Procedural Volume by Type (millions), 2019-2024 (HAIs, Hepatitis, HIV, HPV, GC/Chlamydia, Respiratory, Mycobacteria/TB, Organism ID, Other)
- Blood Screening
- Cancer
- Transplant Matching
- Thrombophilia SNPs and Inherited Diseases
- Pharmacodiagnostic Tests
Global Sales of Molecular IVD Products
- Table 9-3 Molecular Assay Product Sales by Type ($ millions), 2019-2024 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
- Table 9-4 Molecular Assay Infectious Disease Product Sales by Type ($ millions), 2019-2024 (HAIs, Hepatitis, HIV, HPV, GC/Chlamydia, Respiratory, Mycobacteria/TB, Organism ID, Other)
Pricing Trends
- Table 9-5 Molecular Assays $ Products per Procedure by Type, 2019-2024 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
Ten: Hematology Procedures
- Table 10-1 Hematology Procedural Volume by Type (millions), 2019-2024 (Complete Blood Count, Other Hematology Tests)
Types of Tests
- Global Sales of Hematology Products
- Table 10-2 Hematology Product Sales by Type ($ millions), 2019-2024 (Complete Blood Count, Other Hematology Tests)
- Pricing Trends
- Table 10-3 Hematology $ Product Sales Per Procedure by Type, 2019-2024 (Complete Blood Count, Other Hematology Tests)
Eleven: Coagulation Testing Procedures
- Table 11-1 Coagulation Procedural Volume (millions), 2019-2024
Types of Tests
- Global Sales of Coagulation Products
- Table 11-2 Coagulation Product Sales ($ millions), 2019-2024
- Pricing Trends
- Table 11-3 Coagulation $ Products per Procedure, 2019-2024
Twelve: Microbiology Procedures
- Table 12-1 Conventional Microbiology Procedural Volume by Type (millions), 2019-2024 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
Types of Tests
- Chromogenic Media
- ID/AST Automated Panels & Reagents
- Blood Culture
- Manual Panels & Reagents
- Rapid Microbiological Tests
Global Sales of Conventional IVD Microbiology Products
- ID/AST Panels & Reagents
- Chromogenic Media
- Blood Culture
- Rapid Microbiological Tests
- Table 12-2 Conventional Microbiology Product Sales by Type ($ millions), 2019-2024 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
- Pricing Trends
- Table 12-3 Conventional Microbiology $ Product Sales Per Procedures by Type, 2019-2024 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
Thirteen: Blood Grouping/Typing Procedures
- Table 13-1 Blood Grouping/Matching Procedural Volume (millions), 2019-2024
Types of Tests
- Blood Grouping/Matching Product Sales
- Table 13-2 Blood Grouping/Matching Product Sales ($ millions), 2019-2024
- Pricing Trends
- Table 13-3 Blood Grouping/Matching $ Product Sales/Procedure, 2019-2024
Fourteen: Histology/Cytology Procedures
- Table 14-1 Histology/Cytology Procedural Volume by Type (millions), 2019-2024 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
Types of Tests
- In Situ Hybridization Tests
- Immunohistochemistry Tests
- Pap Tests
- Traditional Non-Pap Stains
- Circulating Tumor Cells
Histology/Cytology IVD Product Sales
- Table 14-2 Histology/Cytology Product Sales by Type ($ millions), 2019-2024 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
Pricing Trends
- Table 14-3 Histology/Cytology $ Product Sales Per Procedure by Type, 2019-2024 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
Fifteen: Company Profiles
- Table 15-1: Revenues of Selected Top IVD Companies, 2014-2018 ($ million, estimated)
- Abbott Laboratories
- Table 15-2 Abbott Diagnostics Global IVD Procedural Volume by Type, 2019 (million) (POC, CC, Imm, Molecular, Hema, Hist/Cyt)
- Becton, Dickinson, and Company (BD)
- bioMÈrieux Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Table 15-3 Danaher Global IVD Procedural Volume by Type, 2019 (million) (POC, CC, Imm, Molecular, Hema, Microbiology, Hist/Cyt)
- Hologic, Inc.
- Ortho Clinical Diagnostics (Ortho)
- QIAGEN N.V.
- Roche
- Table 15-4 Roche Diagnostics Global IVD Procedural Volume by Type, 2019 (million) (POC, CC, Imm, Molecular, Hema, Hist/Cyt)
- Siemens Healthineers
- Table 15-5 Siemens Healthineers Global IVD Procedural Volume by Type, 2019 (million) (POC, CC, Imm, Molecular, Hema, Coag, Microbiology)
- Sysmex Corporation
- Table 15-6 Sysmex Global IVD Procedural Volume by Type, 2019 (million) (POC, CC, Imm, Hema, Coag, Hist/Cyt)
- Thermo Fisher Scientific Inc.
- Clinical Diagnostics
- Immunodiagnostics
- Microbiology
- Transplant Diagnostics
- Molecular Testing
- IVD Procedural Volume
- Table 15-7 Thermo Fisher Scientific Global IVD Procedural Volume by Type, 2019 (million) (POC, CC, Imm, Molecular, Microbiology, Hist/Cyt)
Samples
LOADING...
Companies Mentioned
- Abbott Laboratories
- Becton, Dickinson and Company (BD)
- bioMérieux Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Hologic, Inc.
- Ortho Clinical Diagnostics (Ortho)
- QIAGEN N.V.
- Roche
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
![In-Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2030 - Product Image](http://www.researchandmarkets.com/product_images/12002/12002788_60px_jpg/invitro_diagnostics_market.jpg)
